Abstract
This case is notable for the potential overlap of hereditary alpha tryptasemia and eosinophilic granulomatosis with polyangiitis. The successful use of mepolizumab, initially for eosinophilic granulomatosis with polyangiitis but potentially benefiting the patient's hereditary alpha tryptasemia, offers a novel approach to managing complex cases involving both rare disorders.
| Original language | English |
|---|---|
| Article number | 100481 |
| Journal | Journal of Allergy and Clinical Immunology: Global |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - Aug 2025 |
Keywords
- elevated tryptase level
- eosinophilic granulomatosis with polyangiitis
- Hereditary alpha tryptasemia
- hypereosinophilia
- mepolizumab